BioInvent International
Martin has worked in the pharma and biotech industry since 2003 (QPharma, Novozymes and Repligen), and has extensive experience in GMP and chromatography. Born 1979.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
BioInvent International
BioInvent International AB (Nasdaq Stockholm: BINV) is a clinical-stage biotech company that discovers and develops novel and first-in-class immuno-modulatory antibodies for cancer therapy, with currently three drug candidates in four ongoing clinical programs in Phase l/ll trials for the treatment of hematological cancer and solid tumors, respectively.